Dow Jones

39,118.86

-0.12%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

BRL

Barr (BRL)

Barr Pharmaceuticals

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:BRL

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
19/03/2013	06:30	Zacks	Is It Time to Buy the Brazil ETF (EWZ)? - ETF News And Commentary	NYSE:BRL	Barr Pharmaceuticals
03/09/2010	03:05	DPA AFX Nachrichten	AKTIE IM FOKUS: Bayer leicht im Plus - Dämpfer im Yasmin-Streit in den USA	NYSE:BRL	Barr Pharmaceuticals
16/06/2010	01:15	DPA AFX Nachrichten	Aktien Frankfurt Ausblick: Freundlich erwartet – Rückenwind aus den USA	NYSE:BRL	Barr Pharmaceuticals
22/12/2008	16:00	PR Newswire (US)	Warner Chilcott and Barr Announce Settlement of Femcon(R) Fe Patent Challenge	NYSE:BRL	Barr Pharmaceuticals
22/12/2008	14:23	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NYSE:BRL	Barr Pharmaceuticals
19/12/2008	14:00	Business Wire	U.S. Federal Trade Commission Clears Teva’s Acquisition of Barr	NYSE:BRL	Barr Pharmaceuticals
19/12/2008	14:00	PR Newswire (US)	U.S. Federal Trade Commission Clears Teva's Acquisition of Barr	NYSE:BRL	Barr Pharmaceuticals
19/12/2008	13:19	PR Newswire (US)	Teva and Barr Receive European Commission Approval For Acquisition	NYSE:BRL	Barr Pharmaceuticals
19/12/2008	12:25	Business Wire	Teva and Barr Receive European Commission Approval for Acquisition	NYSE:BRL	Barr Pharmaceuticals
19/12/2008	12:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:BRL	Barr Pharmaceuticals
18/12/2008	17:09	PR Newswire (US)	Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. Indices	NYSE:BRL	Barr Pharmaceuticals
11/12/2008	08:53	PR Newswire (US)	Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA	NYSE:BRL	Barr Pharmaceuticals
08/12/2008	12:15	Business Wire	Teva Draws on $1.75 Billion Bridge Financing in Connection with Pending Barr Acquisition	NYSE:BRL	Barr Pharmaceuticals
01/12/2008	08:06	PR Newswire (US)	FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream	NYSE:BRL	Barr Pharmaceuticals
26/11/2008	11:20	PR Newswire (US)	Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg	NYSE:BRL
21/11/2008	15:44	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:BRL	Barr Pharmaceuticals
21/11/2008	13:00	PR Newswire (US)	Barr Shareholders Approve Pending Teva Acquisition	NYSE:BRL	Barr Pharmaceuticals
20/11/2008	16:30	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NYSE:BRL	Barr Pharmaceuticals
19/11/2008	07:00	PR Newswire (US)	Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation	NYSE:BRL	Barr Pharmaceuticals
19/11/2008	00:30	PR Newswire (US)	Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges	NYSE:BRL	Barr Pharmaceuticals
06/11/2008	14:03	Edgar (US Regulatory)	Quarterly Report (10-Q)	NYSE:BRL	Barr Pharmaceuticals
06/11/2008	06:30	PR Newswire (US)	Barr Reports Third Quarter 2008 GAAP Earnings of $0.28 Per Share; Adjusted Earnings of $0.83 Per Share	NYSE:BRL	Barr Pharmaceuticals
03/11/2008	12:41	PR Newswire (US)	Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL	NYSE:BRL	Barr Pharmaceuticals
27/10/2008	16:30	Business Wire	Teva and Barr Provide Update on Acquisition	NYSE:BRL	Barr Pharmaceuticals
27/10/2008	08:12	PR Newswire (US)	FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive	NYSE:BRL	Barr Pharmaceuticals
24/10/2008	11:46	PR Newswire (US)	Barr Confirms Patent Challenge of Oxytrol(R)	NYSE:BRL	Barr Pharmaceuticals
21/10/2008	12:23	PR Newswire (US)	Barr Confirms Patent Challenge of Opana(R) ER Extended-Release Tablets, 5 mg, 10 mg, 20 mg and 40 mg	NYSE:BRL	Barr Pharmaceuticals
17/10/2008	15:03	PR Newswire (US)	Barr Revises Timing of Its Earnings Conference Call to Discuss the Results for the Third Quarter of Calendar 2008 to 9:00 AM Eas	NYSE:BRL	Barr Pharmaceuticals
16/10/2008	10:28	PR Newswire (US)	Barr Says Court of Appeals Upholds 2005 District Court Decision on 1997 Cipro(R) Settlement	NYSE:BRL	Barr Pharmaceuticals
16/10/2008	09:01	PR Newswire (US)	Barr Announces Date for Special Shareholder Meeting	NYSE:BRL	Barr Pharmaceuticals